Tweet
D.A. Davidson & CO. reduced its position in shares of CIGNA Co. (NYSE:CI) by 16.1% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,735 shares of the health services provider's stock after selling 333 shares during the quarter. D.A. Davidson & CO.'s holdings in CIGNA were worth $295,000 at the end of the most recent quarter.
Other hedge funds have also recently bought and sold shares of the company. Veritas Asset Management LLP acquired a new position in CIGNA during the 1st quarter worth approximately $409,675,000. Wells Fargo & Company MN boosted its holdings in shares of CIGNA by 1.5% in the 1st quarter. Wells Fargo & Company MN now owns 1,869,196 shares of the health services provider's stock valued at $313,539,000 after buying an additional 26,729 shares in the last quarter. Fulton Bank N.A. boosted its holdings in shares of CIGNA by 27.3% in the 1st quarter. Fulton Bank N.A. now owns 2,251 shares of the health services provider's stock valued at $378,000 after buying an additional 483 shares in the last quarter. Twin Capital Management Inc. boosted its holdings in shares of CIGNA by 39.3% in the 1st quarter. Twin Capital Management Inc. now owns 7,778 shares of the health services provider's stock valued at $1,305,000 after buying an additional 2,193 shares in the last quarter. Finally, Wealthstreet Investment Advisors LLC boosted its holdings in shares of CIGNA by 12.5% in the 1st quarter. Wealthstreet Investment Advisors LLC now owns 14,085 shares of the health services provider's stock valued at $2,363,000 after buying an additional 1,560 shares in the last quarter. 88.96% of the stock is currently owned by institutional investors and hedge funds. Get CIGNA alerts:
Several research analysts have recently issued reports on the stock. SunTrust Banks upped their target price on shares of CIGNA to $244.00 and gave the company a "buy" rating in a report on Friday, August 3rd. Jefferies Financial Group restated a "buy" rating and issued a $224.00 target price on shares of CIGNA in a report on Friday, August 3rd. ValuEngine upgraded shares of CIGNA from a "sell" rating to a "hold" rating in a report on Friday, August 3rd. Zacks Investment Research upgraded shares of CIGNA from a "hold" rating to a "buy" rating and set a $212.00 target price for the company in a report on Tuesday, August 7th. Finally, Credit Suisse Group upped their target price on shares of CIGNA from $215.00 to $218.00 and gave the company an "outperform" rating in a report on Friday, May 4th. One analyst has rated the stock with a sell rating, two have issued a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. The company currently has a consensus rating of "Buy" and an average price target of $221.77. Shares of NYSE:CI opened at $188.19 on Friday. The firm has a market cap of $44.60 billion, a P/E ratio of 17.99, a price-to-earnings-growth ratio of 1.08 and a beta of 0.60. The company has a quick ratio of 0.38, a current ratio of 0.38 and a debt-to-equity ratio of 0.35. CIGNA Co. has a 1-year low of $163.02 and a 1-year high of $227.13.
CIGNA (NYSE:CI) last issued its quarterly earnings results on Thursday, August 2nd. The health services provider reported $3.89 earnings per share for the quarter, topping the Zacks' consensus estimate of $3.33 by $0.56. The firm had revenue of $11.50 billion during the quarter, compared to analysts' expectations of $11.20 billion. CIGNA had a net margin of 5.82% and a return on equity of 22.27%. CIGNA's quarterly revenue was up 10.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.91 EPS. research analysts expect that CIGNA Co. will post 13.87 earnings per share for the current fiscal year.
In other CIGNA news, CFO Eric P. Palmer purchased 2,828 shares of the firm's stock in a transaction that occurred on Tuesday, July 31st. The stock was purchased at an average price of $177.61 per share, for a total transaction of $502,281.08. Following the purchase, the chief financial officer now directly owns 9,678 shares in the company, valued at $1,718,909.58. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website . Also, VP Hoeltzel Mary T. Agoglia sold 1,000 shares of the stock in a transaction on Friday, May 25th. The stock was sold at an average price of $176.19, for a total transaction of $176,190.00. Following the sale, the vice president now owns 4,635 shares of the company's stock, valued at approximately $816,640.65. The disclosure for this sale can be found here . 1.10% of the stock is owned by corporate insiders.
CIGNA Profile
Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.
See Also: Fundamental Analysis and Choosing Stocks
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CIGNA Co. (NYSE:CI). Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter 